New 'Off-the-Shelf' cell therapy takes on Hard-to-Treat blood cancers
NCT ID NCT05878184
First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 36 times
Summary
This early-stage study tests a new treatment called SC291 for people with certain types of blood cancer (non-Hodgkin lymphoma or chronic lymphocytic leukemia) that have come back or not responded to other treatments. SC291 is a type of immune cell therapy made from donor cells, designed to target and kill cancer cells. The main goal is to check if the treatment is safe and to see if it can shrink tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Linear Clinical Research Ltd
Nedlands, Western Australia, 6009, Australia
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Northside Hospital
Atlanta, Georgia, 30342, United States
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, 3000, Australia
-
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
-
Stanford Cancer Institute
Palo Alto, California, 94304, United States
-
University of Kansas Medical Center
Fairway, Kansas, 66205, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
Conditions
Explore the condition pages connected to this study.